EUVIMEDEUVIMED entdecken
Crossref

Association Between plasma Angiotensinogen level and response to valsartan among sample of hypertensive Iraqi patients

Haneen Sajid Mahmoud, Hussein A Saheb, Bassim Mohammad, Ahmed M Sultan, Sinaa Abdul Amir Kadhim, Asma A Swadi

Wiadomości Lekarskie · 2024

DOI: 10.36740/wlek/191331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiadomości Lekarskie, 2024. Verfasst von Haneen Sajid Mahmoud und 5 weiteren Autor:innen. Beteiligte Einrichtung: DEPARTMENT OF PHARMACOLOGY AND THERAPEUTICS, COLLEGE OF MEDICINE, UNIVERSITY OF AL-QADISIYAH, AL-QADISIYAH, IRAQ. Hauptthemen laut MEDLINE: Valsartan, Angiotensinogen, Hypertension, Antihypertensive Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Aims: to ascertain if AGT polymorphism [rs699 (T235M), rs5051 (A-6G)] affects the success of valsartan treatment for essential hypertension in Iraqi patients, here, we demonstrate that two of these variations contribute nothing to the clinical response to valsartan. Material and methods Data obtained at the Al-Diwaniyah teaching hospital in Iraq by researchers from the Department of Pharmacology and Therapeutics in the College of Medicine at University of Al-Qadisiyah from July 2022 to July 2023. All participants (aged 20 to 70) had been taking valsartan 160 mg once day for essential hypertension for at least two weeks before to the study. There were a total of 90 participants, 37 males and 53 women. Initial investigations of hypertension have indicated that the angiotensinogen gene has a substantial impact in susceptibility to essential hypertension through observational cross sectional descriptive single center study.

Results

Indicate, in patients with essential hypertension, that the "AGT gene A>G (rs699) and C>T(rs5051)" have high angiotensinogen level, and there is no significant association between these two (rs699, rs5051) and responsiveness to valsartan (P >0.05).

Conclusions

There is no significant association between these two (rs699, rs5051) and responsiveness to valsartan (P >0.05).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ValsartanAngiotensinogenHypertensionAntihypertensive AgentsHumansMaleFemaleIraqMiddle AgedAdultCross-Sectional StudiesAgedNitric Oxide Synthase Type IIIEssential HypertensionYoung AdultGene FrequencyPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

AGT GenIraqessential hypertensionpolymorphismvalsartan

Substanzen

ValsartanAngiotensinogenAntihypertensive AgentsNitric Oxide Synthase Type III

Autor:innen und Institutionen

  • DEPARTMENT OF PHARMACOLOGY AND THERAPEUTICS, COLLEGE OF MEDICINE, UNIVERSITY OF AL-QADISIYAH, AL-QADISIYAH, IRAQ.

Zitieren

APA

Mahmoud, H. S., Saheb, H. A., Mohammad, B., Sultan, A. M., Kadhim, S. A. A., & Swadi, A. A. (2024). Association Between plasma Angiotensinogen level and response to valsartan among sample of hypertensive Iraqi patients. Wiadomości Lekarskie. https://doi.org/10.36740/wlek/191331

Vancouver

Mahmoud HS, Saheb HA, Mohammad B, Sultan AM, Kadhim SAA, Swadi AA. Association Between plasma Angiotensinogen level and response to valsartan among sample of hypertensive Iraqi patients. Wiadomości Lekarskie. 2024. doi:10.36740/wlek/191331

BibTeX
@article{Mahmoud2024,
  author = {Mahmoud, Haneen Sajid and Saheb, Hussein A and Mohammad, Bassim and Sultan, Ahmed M and Kadhim, Sinaa Abdul Amir and Swadi, Asma A},
  title = {Association Between plasma Angiotensinogen level and response to valsartan among sample of hypertensive Iraqi patients},
  journal = {Wiadomości Lekarskie},
  year = {2024},
  doi = {10.36740/wlek/191331}
}
Kostenlos starten →